LOBE — Lobe Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$13.47m
- CA$8.95m
Annual cashflow statement for Lobe Sciences, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.8 | -12.3 | -4.71 | -4.42 | -4.86 |
| Amortisation | |||||
| Non-Cash Items | 17.6 | 8.66 | 1.43 | 2.54 | 1.28 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.185 | 0.848 | 1.52 | 1.33 | 2.16 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -5.04 | -2.73 | -1.72 | -0.462 | -1.42 |
| Capital Expenditures | -0.137 | 0 | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.2 | 1.74 | 0 | — | -1.69 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.07 | 1.74 | 0 | — | -1.69 |
| Financing Cash Flow Items | -0.198 | -0.043 | -0.102 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.92 | 0.753 | 0.95 | 0.564 | 8.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.97 | -0.234 | -0.767 | 0.097 | 5.62 |